Candriam SCA’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.85M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $11.8M | Hold |
|
|||||
|
2024
Q1 | $13.3M | Hold |
|
|||||
|
2023
Q4 | $12.6M | Sell |
|
|||||
|
2023
Q3 | $8.88M | Sell |
|
|||||
|
2023
Q2 | $18.7M | Sell |
|
|||||
|
2023
Q1 | $19.7M | Buy |
|
|||||
|
2022
Q4 | $21.8M | Buy |
|
|||||
|
2022
Q3 | $11.8M | Buy |
|
|||||
|
2022
Q2 | $7.84M | Buy |
|
|||||
|
2022
Q1 | $9.45M | Sell |
|
|||||
|
2021
Q4 | $15M | Buy |
|
|||||
|
2021
Q3 | $9.73M | Sell |
|
|||||
|
2021
Q2 | $13.4M | Buy |
|
|||||
|
2021
Q1 | $5.79M | Hold |
|
|||||
|
2020
Q4 | $6.03M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.35M | Sell |
|
|||||
|
2015
Q3 | $1.39M | Sell |
|
|||||
|
2015
Q2 | $4.16M | Sell |
|
|||||
|
2015
Q1 | $4.88M | Buy |
|
|||||
|
2014
Q4 | $2.56M | Buy |
|